FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
Regeneron and Sanofi's Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a ...
5 COVID skin rashes: Dermatologists share tips to identify and treat viral skin conditions
We tend to think of COVID-19 as a respiratory illness. But, like many viruses, COVID can also affect your skin and cause ...